Literature DB >> 12360562

Long-term course of restless legs syndrome in dialysis patients after kidney transplantation.

Juliane Winkelmann1, Anette Stautner, Walter Samtleben, Claudia Trenkwalder.   

Abstract

Restless legs syndrome (RLS) is a common cause of sleep disturbance and is frequently experienced by hemodialysis patients. Factors triggering the disease in uremia have not yet been identified. To our knowledge, the course of RLS symptoms after kidney transplantation has not been investigated systematically. We investigated the clinical long-term course of RLS in hemodialysis patients who underwent kidney transplantation. Patients were given a standardized questionnaire three times: at baseline, and twice after their kidney transplants. The severity of RLS was rated by the patients (0 =no symptoms, 10 = very severe symptoms). The description of the final outcome was based on the last follow-up visit. Eleven of 64 hemodialysis patients with RLS received a transplant (5 men, 6 women; severity of RLS at baseline, 7.8 +/- 0.7 [mean +/- SEM]). In all patients, RLS symptoms disappeared within 1 to 21 days after transplantation. At follow-up visits, 4 patients whose transplanted kidneys still functioned well were still free of RLS symptoms up to the longest follow-up period of 9 years. In 3 other patients, RLS symptoms gradually reappeared (severity, 1 +/- 0). In 3 of 11 patients, the transplant failed and RLS symptoms reoccurred within 10 days to 2 months (severity, 7.3 +/- 2.6). RLS symptoms reoccurred in 1 patient with failure of the transplant but disappeared again after a second, successful transplant. Kidney transplantation has a strong and positive influence on RLS symptoms in hemodialysis patients. Hemodialysis patients can expect a substantial improvement of RLS symptoms after a successful kidney transplant. Copyright 2002 Movement Disorder Society.

Entities:  

Mesh:

Year:  2002        PMID: 12360562     DOI: 10.1002/mds.10231

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

Review 1.  Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Authors:  Svenja Happe; Claudia Trenkwalder
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

Review 3.  Management of restless legs syndrome in patients on dialysis.

Authors:  Miklos Z Molnar; Marta Novak; Istvan Mucsi
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Restless legs syndrome: a unique case and essentials of diagnosis and treatment.

Authors:  Pinky Agarwal; Alida Griffith
Journal:  Medscape J Med       Date:  2008-12-31

5.  Sleep Medicine: Restless Legs Syndrome.

Authors:  Pradeep C Bollu; Anudeep Yelam; Mahesh M Thakkar
Journal:  Mo Med       Date:  2018 Jul-Aug

6.  Poor sleep in organ transplant recipients: self-reports and actigraphy.

Authors:  M Reilly-Spong; T Park; C R Gross
Journal:  Clin Transplant       Date:  2013-10-01       Impact factor: 2.863

7.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 8.  Sleep-related movement disorders.

Authors:  Giovanni Merlino; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2011-12-28       Impact factor: 3.307

Review 9.  Sleep disorders and quality of life in renal transplant recipients.

Authors:  Miklos Zsolt Molnar; Marta Novak; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

10.  Restless legs syndrome in children with chronic kidney disease.

Authors:  Sandeep K Riar; Roberta M Leu; Taieshia C Turner-Green; David B Rye; Salathiel R Kendrick-Allwood; Courtney McCracken; Donald L Bliwise; Larry A Greenbaum
Journal:  Pediatr Nephrol       Date:  2013-01-20       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.